Known Medicine

Drug response is hard to predict from standard models, leading to failed treatments and low clinical success rates.

The company uses patient-specific 3D micro-tumor cultures combined with AI to test many drugs and predict which therapies a patient’s tumor will respond to.

Oncologists, hospitals, and biopharma teams use it to guide treatment selection and evaluate drug efficacy.